• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×
  • 28 Nov 16
title

Setting out my stall...plus my thoughts on bond proxies

  • 3004 views
The Naked Fund Manager

UK-focused Small and Mid-cap fund manager.

 
Has the big rotation begun?
Strap line

Has the big rotation out of Bond Proxies into Cyclicals begun?

Companies: BHP Group Ltd, Reckitt Benckiser Group plc


Body


I'm a fund manager working in the city and focused on UK small and mid-cap companies. I've managed money there for most of the last decade and before that worked as a buyside analyst.

 

It's fair to say there is a host of myths and misconceptions about the industry in which I work. Some of it is encouraged to build mystique and therefore brand. Some, in my humble opinion, comes from a lack of transparency when looking from the outside.

 

I'd been thinking about capturing my thoughts periodically for a few years now, mainly to help focus my views about markets. So when the guys at Research Tree approached me about a weekly column, it felt like the right time to start.


 

My 5 point mission statement for this column:

 

  • Only write down stuff I find interesting - If I don't think it's interesting you certainly won't so why waste everyone's time?

  • Be brief! - Like all fund managers, I get bombarded with information all day, much could be written in half the words (and some not at all).

  • Be clear how I think about stocks - I promise to try not to bore but I thought it necessary to give an idea of my process (see below).

  • Share what I've learnt (or re-learnt) that week - This includes actions by corporates that annoy or impress me, red flags, funny anecdotes, interesting themes, etc.

  • Remain anonymous - Sorry I know this might irritate some readers, but I genuinely think I can be more honest, less guarded and therefore more interesting if I maintain anonymity. 

 

 

How I think about valuation

I've always been an unabashed borrower of other people's good ideas. And there's no shame in using a philosophy that has worked for other people as a starting point for managing your own investments. I try to manage my fund using a combination of growth, value and quality principles. The investors that I try to emulate are Greenblatt, Klarman, Lynch and Buffett. That's a very easy sentence to write but a tough job to implement.

 

I use various screens as a starting point:

 

  • High Return on Capital Employed and Earnings Yield are important metrics to narrow down my efforts to companies with high-quality earnings engines that trade at reasonable prices (a la Greenblatt).

  • High Operating Margins and Operating Cash Flow help narrow in on companies that can better weather downturns.

These screens give me a shortlist from which the real work begins. I won't pretend that I have in-depth models and valuations for each of the companies on my radar. I'd never see my kids or wife if I did. But you shouldn't need to.

 

Broker research is always a good starting point in covering the key issues, and I make sure I meet management. My models are simple and quick to update, meaning they're never going to be 100% on the money, but they will capture the essential moving parts and highlight risks and opportunities.

 

The usual factors I then consider are:

  • Management track record,
  • Accounting red flags,
  • Potential addressable market size, and
  • Competitive landscape, among others.

However one other important factor I focus on (thanks to Klarman) is the need to have a big enough market to reinvest in. It's all well and good finding high ROCE companies, but if their niche is too small, the wonders of compounding can never be realised. In these cases, the company normally has to distribute these high returns to shareholders through dividends. This is fine, but compounding is so much better.


And now onto a theme I think is especially interesting right now...


 

Has the big rotation out of bond-proxies begun?

The topics I want to highlight this week are rising yields, the future of bond-proxies/defensive stocks, and whether we are at the tipping point of huge rotation out of Defensives and into Cyclicals. It starts with the chart below but what I find fascinating is the question of whether this recent reversal of a trend that has been in place for the last 5+ years will continue.

 

 

rotation out of defensives and into cyclicals november 2016

 

 

In the above 5-year chart, I've picked the well-known defensive name of Reckitts and plotted it against a cyclical stock, BHP Billiton. The orange line is the 10yr UK Gilt yield. I could have chosen many examples, and they would show the same trend. After years of Defensives outperforming Cyclicals, there has been the start of a reversal. Many of these defensives and "bond proxies" are still trading at lofty multiples. For example, Reckitts is trading on a PE ratio of over 31x (trailing 12 months).


What's driving the rotation and will it continue?

 

Below shows the UK 10yr Government Bond yield for the last five years. It hit all-time lows of 0.5% back in mid-August but has been on a streak ever since. Inflation expectations have returned with the US Fed almost certain to raise rates ahead of the Christmas break, and Brexit will drive inflation even further this side of the pond.

 

 

UK 10yr Govt Bond yields rising

 

 

This trend started before Trump was elected but look at recent events. The new-look era of Trumponomics in the US is set to bring a massive increase infrastructure spend. And in little old England, our Chancellor Hammond recently loosened the austerity belt in the Autumn Statement by removing the target to eradicate the deficit by 2020. In short, debt levels are set to rise, inflation looks to be inevitable, and hopefully increased capital investment might herald some proper growth.


Trump's economic adviser Anthony Scaramucci gives an insight into the changes we can now expect in the US:

  • "Trump would ideally like to see corporate tax rates cut to 15% from 35%."

  • "Business people like Mr Trump understand you can grow yourself out of excessive debt."

  • Trump's $1 trillion infrastructure plan will be "financed by historically cheap debt and public-private partnerships"


This is quite a "top-down" theme to start my blog with but in terms of significant financial trends, Defensive stocks offering "bond-proxy" yields have been where an enormous amount of money has been sitting as a result of our ultra-low interest rate world. If yields are rising this could be the start of that trend unwinding. It doesn't take a genius to realise capital flows of that scale would weigh on defensives vs. cyclicals.


-----

 

Please Note: To be clear, I do not and will not ever give any advice. I will rarely mention individual stocks but when I do these will not be recommendations, instead just my thoughts at that point in time.

 


Body Two

Body Three

Body Four

Body Five

The information contained within this post is based on personal experience and opinion and should not be considered as a recommendation to trade nor financial advice.

More Content

More Content

SP Angel Morning View: Copper edges lower as BHP CEO warns of rising economic risks from tariffs

Companies: PLS AAUC EUA POW KMR GRL BHP GMET MET1 KMR

SP Angel

THE NAKED FUND MANAGER - Why the best businesses have great cash conversion

Companies: IOMPHDCRWRKTRELRMVMCROJE/ZPGINFOTBPTEC0GD5

Research Tree

VSA Capital Morning Miner 200325

Companies: IVNCAMLBHPEST

VSA Capital

How will markets react post election?

Companies: ANTOBBYHLMAHILSSABKIERIOCLLNSHRSSN/GSKBABAZNULVRFRESBHP

Research Tree

VSA Capital Morning Miner 110325

Companies: CBEBHPWR1

VSA Capital
next
 
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • Chrome Extension
  • iOS and Android Apps
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2025

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Acquisdata
      • Actinver
      • Actio Advisors
      • Asset TV
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Brand Communications
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD (hosted by Progressive)
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Edge Group
      • The Life Sciences Division
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Align Research
      • Allenby Capital
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • Allenby Capital
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In